IGF-1 LR3: Receptor Pharmacology and Anabolic Cascade Biology IGF-1 LR3 is a 83-amino acid variant of IGF-1 bearing an N-terminal 13-amino acid Arg extension and a GluArg substitution at position 3, which reduces IGFBP-3 binding affinity by approximately 1000-fold relative to native IGF-1
Even though there are no studies or clinical trials that show BPC-157 is safe or effective in humans, some websites related to performance-enhancing drugs advertise that it can be injected or taken orally for bone and joint healing, stomach ulcers, organ damage, and a number of other purposes, including athletic performance enhancement
This therapy is ideal for athletes, active individuals, and anyone seeking to optimize their body's natural healing processes
This transformation in health consciousness also includes new perspectives in diet, lifestyle, emotional and spiritual development, and complementary health care
Thank you all